Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Nanalysis Provides Fourth Quarter Preview (Unaudited)

Newswire.ca - Thu Feb 27, 2025

Achieves Record Quarterly Adjusted EBITDA of at least $1 Million & Positive Free Cash-Flow

CALGARY, AB, Feb. 27, 2025 /CNW/ - Nanalysis Scientific Corp. "the Company", (TSXV: NSCI), (OTCQX: NSCIF), (FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications, provides an estimate of Q4 2024 unaudited revenue, adjusted EBITDA, and highlights some other recent business accomplishments. These unaudited numbers may change materially before filings in April.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).